Regenerative Medical Technology (RMTG) Current Leases (2022 - 2026)

Regenerative Medical Technology has reported Current Leases for 5 years, with the latest figure at $157681.0 in Q2 2026.

• On a quarterly basis, Current Leases rose 145.7% year-over-year to $157681.0 in Q2 2026; TTM through Jun 2026 was $157681.0, a 145.7% increase from a year earlier, with the FY2025 full-year figure at $219973.0, up 246.2% from the prior year.
• Current Leases was $157681.0 for Q2 2026 at Regenerative Medical Technology, down from $165567.0 in the prior quarter.
• The five-year high for Current Leases was $219973.0 in Q4 2025, with the low at $2714.0 in Q4 2023.
• Average Current Leases over 5 years is $74369.8, with a median of $63858.0 recorded in 2024.
• The sharpest annual moves came in 2023 and 2024: Current Leases tumbled 91.67% in 2023, then surged 2241.19% in 2024.
• Over 5 years, Current Leases stood at $32568.0 in 2022, then sank by 91.67% to $2714.0 in 2023, then soared by 2241.19% to $63540.0 in 2024, then jumped by 246.2% to $219973.0 in 2025, then declined by 28.32% to $157681.0 in 2026.
• The last three Current Leases figures came in at $157681.0 (Q2 2026), $165567.0 (Q1 2026), and $219973.0 (Q4 2025), per Business Quant data.